Moreover, given the association of elevated IL-6 levels with the pathogenesis of multiple sclerosis [63,64] and encephalomyelitis [65,66]—both characterized by demyelination and neurodegeneration—GFAP-IL6 mice may serve as a model to investigate certain neuroinflammatory aspects of these conditions. Here, GFAP is linked to encephalomyelitis.